Hospira Cisplatin 50mg/50mL Solution for Infusion vial

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

有効成分:

cisplatin, Quantity: 1 mg/mL

から入手可能:

Hospira Australia Pty Ltd

INN（国際名）:

Cisplatin

医薬品形態:

Injection, intravenous infusion

構図:

Excipient Ingredients: mannitol; sodium chloride; water for injections; hydrochloric acid; sodium hydroxide

投与経路:

Intravenous Infusion

パッケージ内のユニット:

1 x 50mL vial

クラス:

Medicine Listed (Export Only)

処方タイプ:

(S1) This Schedule is intentionally blank

適応症:

Cisplatin is indicated for the treatment of: Metastatic carcinoma of non-seminoma germinale cells, Advanced and refractory carcinoma of the ovary, Advanced and refractory carcinoma of the bladder, epidemiological carcinoma of the head and the neck.

製品概要:

Visual Identification: a clear, colourless to pale yellow solution free from visible particulates; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 2 Years; Container Temperature: Store between 15-25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

認証ステータス:

Licence status A

承認日:

2009-03-10